title: Estrogen/hypothalamus-pituitary-adrenal axis interactions in the fetus: The interplay between placenta and fetal brain.
abstract: OBJECTIVE
  The hormonal interactions between the placenta and the fetal hypothalamus-pituitary-adrenal (HPA) axis are reviewed.
  
  
  METHODS
  This review addresses data obtained from the chronically catheterized fetal sheep, drawing relevant comparisons to human fetuses.
  
  
  RESULTS
  In the sheep, and perhaps in primate species, parturition is initiated by an increase in the activity of the HPA axis. The endogenous mechanisms underlying the increase in activity of the fetal HPA axis are incompletely understood but might involve an interplay between placenta and fetal hypothalamus and pituitary. Various hypotheses have been proposed, involving placental secretion of prostaglandins and various components of the fetal HPA axis. In the sheep, the influence of estradiol appears to be potent, and various experiments have suggested the possibility that, in late gestation, there exists a positive feedback relationship between placental estrogen secretion and pituitary adrenocorticotropin (ACTH) secretion. Estradiol circulates in concentrations known to stimulate fetal ACTH secretion. Additionally, estradiol circulates in the form of estradiol-3-sulfate, a molecular form that is taken up by the fetal brain and deconjugated by steroid sulfatase, which is expressed in the fetal brain. Recent evidence suggests that the interaction between estradiol and ACTH might involve production of paracrine or autocrine substances in the fetal brain. One candidate mediator is prostaglandin E2 (PGE2), highlighted by the action of estradiol on the expression of prostaglandin endoperoxide synthase-2 (PGHS-2 or COX-2) in brain regions known to be important for controlling HPA activity.
  
  
  CONCLUSIONS
  Estradiol, secreted by the placenta in increasing amounts in late gestation, is a potent stimulator of fetal ACTH secretion. The interactions between estradiol and the fetal HPA axis might function as a positive feedback loop that increases the concentrations of both hormones before birth.
authors.affiliation: Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, Florida 32610-0274, USA. cwood@phys.med.ufl.edu
authors.forename: Charles E
authors.initials: CE
authors.lastname: Wood
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000502:physiology; D000818:Animals; D001921:Brain / Q000201:enzymology*; D015232:Dinoprostone / Q000502:physiology; D004958:Estradiol / Q000502:physiology*; D005260:Female; D047109:Fetal Development / Q000502:physiology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000196:embryology*; D023421:Models, Animal; D010913:Pituitary-Adrenal System / Q000196:embryology*; D010920:Placenta / Q000502:physiology*; D011247:Pregnancy; D012756:Sheep / Q000196:embryology*
chemical_list: D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D015232:Dinoprostone